GSK announced on Tuesday that its investigational antibody-drug conjugate GSK'227 has been granted breakthrough therapy ...

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration has granted a breakthrough therapy designation to its treatment for a form of bone cancer.

GSK plc (GSK, GSK.L) said that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for GSK5764227, its ...

London open The FTSE 100 is expected to open 44 points lower on Tuesday, having closed up 0.31% on Monday at 8,249.66.

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Pharma companies in India are expected to report healthy earnings growth in the just-concluded October-December quarter, ...

The LDH revealed that the patient was over age 65, had underlying medical conditions and contracted bird flu after exposure ...

RNA is a long, polymeric molecule, composed of four different building blocks called nucleotides. In the last decade mRNA has progressed into a promising new class of medicine, with the potential to ...

GSK PLC GSK shares inched up 0.71% to £13.50 Monday, on what proved to be an all-around positive trading session for the ...

The China National Medical Products Administration (NMPA) has approved GSK’s Nucala (mepolizumab) as an add-on treatment with ...

DIA's Pharmacovigilance Conference, featuring artificial intelligence and real-world evidence discussions, will be held Jan.

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...